María Jesús Jiménez‐Expósito

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Tania M. Welzel, Jörg Petersen, Kerstin Herzer et al. · Gut · 2016 · 196 citations · Full text

Infective Endocarditis in Patients on Chronic Hemodialysis

Juan M. Pericàs, Jaume Llopis, María Jesús Jiménez‐Expósito et al. · Journal of the American College of Cardiology · 2021 · 64 citations

Hemodialysis, Medicine, Kidney Failure +5

High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy

Carlos Alonso‐Villaverde, Teresa Segués, Blai Coll-Crespo et al. · AIDS · 2003 · 39 citations

Cytokine‐Driven Inflammatory Response Is Associated with the Hypermetabolism of AIDS Patients with Opportunistic Infections

Pilar García‐Lorda, Pilar Serrano, María Jesús Jiménez‐Expósito et al. · Journal of Parenteral and Enteral Nutrition · 2000 · 37 citations

Daclatasvir plus Sofosbuvir, with or without Ribavirin, in Real-World Patients with HIV–HCV Coinfection and Advanced Liver Disease

Jürgen K. Rockstroh, Patrick Ingiliz, Jörg Petersen et al. · Antiviral Therapy · 2016 · 30 citations